Screening and validation of high-risk clinical phenotypes of sleep apnea hypopnea syndrome with cardiovascular disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000040890

Enrollment

Unknown

Registered

2020-12-14

Start date

2015-09-01

Completion date

Unknown

Last updated

2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep breathing disorder

Interventions

group according to different clinical phenotypes:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) They were older than 18 years old; 2) patients diagnosed as OSAHS by PSG; 3) not using or refusing to use CPAP treatment; 4) cooperating with follow-up, they agreed to check and review the relevant indicators.

Exclusion criteria

Exclusion criteria: 1) Patients with mental diseases; 2) with cardiomyopathy, rheumatic heart disease and other serious heart disease; 3) with hypothyroidism; 4) recent obvious changes in diet or exercise habits; 5) liver and renal failure; 6) patients with malignant tumor; 7) patients with drug abuse, drugs or alcohol abuse.

Design outcomes

Primary

Measure	Time frame
MACE;	—

Countries

China

Contacts

Public ContactYongxiang Wei

Beijing Anzhen Hospital, Capital Medical University

weiyongxiang@tom.com+86 10-64456644

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026